Related references
Note: Only part of the references are listed.L-OPA1 deficiency aggravates necroptosis of alveolar epithelial cells through impairing mitochondrial function during acute lung injury in mice
Hui-Ling Jiang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth
Margherita Zamberlan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD plus regeneration in KRas-mutant lung adenocarcinoma
Dane T. Sessions et al.
CELL REPORTS (2022)
OXPHOS promotes apoptotic resistance and cellular persistence in TH17 cells in the periphery and tumor microenvironment
Hanna S. Hong et al.
SCIENCE IMMUNOLOGY (2022)
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma
Chiara Raggi et al.
JOURNAL OF HEPATOLOGY (2021)
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Yuxin Zhao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance
Suntae Kim et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
The mitochondrial protein Opa1 promotes adipocyte browning that is dependent on urea cycle metabolites
Camilla Bean et al.
NATURE METABOLISM (2021)
The cell biology of mitochondrial membrane dynamics
Marta Giacomello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy
Chung-Yu Huang et al.
CANCERS (2020)
Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1
Stephanie Herkenne et al.
CELL METABOLISM (2020)
Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer
Tatiana Shaurova et al.
FRONTIERS IN GENETICS (2020)
MitoSegNet: Easy-to-use Deep Learning Segmentation for Analyzing Mitochondrial Morphology
Christian A. Fischer et al.
ISCIENCE (2020)
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Xufeng Chen et al.
CANCER DISCOVERY (2019)
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2
Tatsunori Nishimura et al.
ONCOGENE (2019)
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Grace R. Anderson et al.
NATURE COMMUNICATIONS (2018)
Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer
Zheng-Zhi Zou et al.
ONCOTARGET (2017)
The Opa1-Dependent Mitochondrial Cristae Remodeling Pathway Controls Atrophic, Apoptotic, and Ischemic Tissue Damage
Tatiana Varanita et al.
CELL METABOLISM (2015)
Evolution of Mitochondria as Signaling Organelles
Navdeep S. Chandel
CELL METABOLISM (2015)
Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells
Imoh S. Okon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma
Yuqing Lou et al.
MEDICAL ONCOLOGY (2015)
Early effects of the antineoplastic agent salinomycin on mitochondrial function
A. Manago et al.
CELL DEATH & DISEASE (2015)
Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs
Asuka Nakata et al.
SCIENTIFIC REPORTS (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale et al.
NATURE (2014)
Mitochondrial Cristae Shape Determines Respiratory Chain Supercomplexes Assembly and Respiratory Efficiency
Sara Cogliati et al.
CELL (2013)
Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells
Sheng-Yi Yu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Mitochondrial Fusion Directs Cardiomyocyte Differentiation via Calcineurin and Notch Signaling
Atsuko Kasahara et al.
SCIENCE (2013)
Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer
Asuka Nakata et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Overexpression of optic atrophy 1 protein increases cisplatin resistance via inactivation of caspase-dependent apoptosis in lung adenocarcinoma cells
Hsin-Yuan Fang et al.
HUMAN PATHOLOGY (2012)
Mitochondria as sensors and regulators of calcium signalling
Rosario Rizzuto et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Mitochondrial quality control: an integrated network of pathways
Fabian Fischer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Metabolic state of glioma stem cells and nontumorigenic cells
Erina Vlashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1
Sarah Ehses et al.
JOURNAL OF CELL BIOLOGY (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization
Ryuji Yamaguchi et al.
MOLECULAR CELL (2008)
Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling
Sara Cipolat et al.
CELL (2006)
OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion
Christian Frezza et al.
CELL (2006)
OPA1 requires mitofusin 1 to promote mitochondrial fusion
S Cipolat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
BAX and BAK regulation of endoplasmic reticulum Ca2+:: A control point for apoptosis
L Scorrano et al.
SCIENCE (2003)
A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis
L Scorrano et al.
DEVELOPMENTAL CELL (2002)
The mitochondrial permeability transition, release of cytochrome c and cell death -: Correlation with the duration of pore openings in situ
V Petronilli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)